ClinicalTrialsFinder

Phase 1 Psoriasis Clinical Trials

32 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–20 of 32 trials

Recruiting
Phase 1

A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

Hidradenitis SuppurativaPsoriatic ArthritisAxial Spondyloarthritis+1 more
UCB Biopharma SRL20 enrolled12 locationsNCT06888193
Recruiting
Phase 1

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmRheumatoid Arthritis+11 more
National Cancer Institute (NCI)300 enrolled52 locationsNCT03816345
Recruiting
Phase 1

Maximal Usage Pharmacokinetics and Safety Study of ARQ-154 Foam 0.3% in Pediatric Participants With Scalp and Body Psoriasis

Psoriasis
Arcutis Biotherapeutics, Inc.16 enrolled5 locationsNCT07340216
Recruiting
Phase 1

Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis

Psoriasis (PsO)Atopic Dermatitis (AD)
LAPIX Therapeutics Inc.48 enrolled3 locationsNCT06982352
Recruiting
Phase 1

Pharmacokinetic, Safety, Tolerability, and Immunogenicity Comparison of CKD-704 (Risankizumab Biosimilar), With EU-approved Skyrizi®, and US-licensed Skyrizi® in Healthy Adult Participants

Psoriasis
Chong Kun Dang Pharmaceutical213 enrolled1 locationNCT07258745
Recruiting
Phase 1

To Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Liver Damage

Psoriasis
Ganzhou Hemay Pharmaceutical Co., Ltd24 enrolled1 locationNCT06376474
Recruiting
Phase 1

A Study of UA026 Tablets in Healthy Adult Subjects and Adult Subjects With Moderate to Severe Plaque Psoriasis

Healthy VolunteerPlaque Psoriasis
Usynova Pharmaceuticals Ltd.124 enrolled1 locationNCT07038720
Recruiting
Phase 1Phase 2

A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasis

Plaque Psoriasis
Chipscreen Biosciences, Ltd.220 enrolled11 locationsNCT07129382
Recruiting
Phase 1

Evaluate the Safety and Pharmacokinetics/Pharmacodynamics of HS-20118

Psoriasis
Jiangsu Hansoh Pharmaceutical Co., Ltd.132 enrolled9 locationsNCT06846710
Recruiting
Phase 1

Evaluate the Safety and Pharmacokinetics/Pharmacodynamics and Food Effect of HS-20118

Psoriasis
Jiangsu Hansoh Pharmaceutical Co., Ltd.142 enrolled1 locationNCT07033234
Recruiting
Phase 1

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of ASC50 Tables in Healthy Participants and Participants With Plaque Psoriasis

Plaque Psoriasis
Ascletis Pharma (China) Co., Limited94 enrolled1 locationNCT07024602
Recruiting
Phase 1

Quantitative Fluorescence Molecular Imaging of Ustekinumab-800CW to Elucidate the Drug Distribution Throughout Inflamed Tissue in Crohn's Disease and Psoriasis.

Crohn DiseasePsoriasis
University Medical Center Groningen56 enrolled1 locationNCT05725876
Recruiting
Phase 1

Study of SFA002 in Patients with Mild to Moderate Psoriasis Plaques

Psoriasis
SFA Therapeutics90 enrolled3 locationsNCT05642182
Completed
Phase 1

Pivotal in vivo bioequivalence study comparing two formulations of betamethsone OV ointment applied to the skin in healthy male and female volunteers.

Diprosone OV ointment is indicated for the topical treatment of eczema and psoriasis in children and adults.
Zenith Technology Corporation Limited90 enrolled1 locationACTRN12624000621516
Completed
Phase 1

Pivotal in vivo bioequivalence study comparing two formulations of betamethsone ointment applied to the skin in healthy male and female volunteers.

Betamethasone ointment is indicated for the topical treatment of eczema and psoriasis in children and adults.
Zenith Technology Corporation Limited90 enrolled1 locationACTRN12624000107527
Completed
Phase 1

Pivotal in vivo bioequivalence study comparing two formulations of 9-fluoro-11ß-hydroxy- 16ß-methyl-3,20-dioxopregna- 1,4-diene-17,21-diyl dipropanoate cream applied to the skin in healthy male and female volunteers.

9-fluoro-11ß-hydroxy- 16ß-methyl-3,20-dioxopregna- 1,4-diene-17,21-diyl dipropanoate cream is indicated for the topical treatment of eczema and psoriasis in children and adults.
Zenith Technology Corporation Limited90 enrolled1 locationACTRN12623001003662
Completed
Phase 1

First-in-Human Study of Oral SDC-1801 in Healthy Adults and Adults with Plaque Psoriasis (Part 3 - Food Effects)

Plaque Psoriasis
Pharmaceutical Solutions Australia Pty Ltd16 enrolled1 locationACTRN12623000419662
Not Yet Recruiting
Phase 1

First-in-Human Study of Oral SDC-1801 in Healthy Adults and Adults with Plaque Psoriasis (Part 4 - Adults with Plaque Psoriasis)

Plaque Psoriasis
Pharmaceutical Solutions Australia Pty Ltd12 enrolled2 locationsACTRN12623000417684
Completed
Phase 1

First-in-Human Study of Oral SDC-1801 in Healthy Adults and Adults with Plaque Psoriasis (Parts 1 and 2)

Plaque Psoriasis
Pharmaceutical Solutions Australia Pty Ltd80 enrolled1 locationACTRN12623000416695
Terminated
Phase 1

A study to Evaluate the Effects of Food on Pharmacokinetics of AC-201.

Psoriasis
Accro Bioscience (Australia) Pty Ltd12 enrolled1 locationACTRN12623000408684